Clinical Trials on Coronary Arteriosclerosis

Total 10588 results

Johns Hopkins University

Completed

Culturally-Tailored Approach to Improve Medication Use in Patients With Heart Attacks

Myocardial Infarction | Coronary Arteriosclerosis

United States
University of Ulster
Belfast Health and Social Care Trust; South Eastern Health and Social Care...

Completed

Effect of a Cardiac Rehabilitation (CR) Programme on Molecular Mechanisms

Myocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis

United Kingdom
University of Pittsburgh
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Epidemiology of Coronary Calcification in the Elderly

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypertension | Coronary Arteriosclerosis
Lundquist Institute for Biomedical Innovation at...
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA

Heart Diseases | Cardiovascular Diseases | Atherosclerosis | Coronary Arteriosclerosis
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Epidemiology of Coronary Artery Calcification (ECAC)

Heart Diseases | Cardiovascular Diseases | Coronary Disease | Atherosclerosis | Coronary Arteriosclerosis
Hartford Hospital
GE Healthcare

Completed

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

Myocardial Ischemia | Coronary Artery Disease | Cardiovascular Disease | Heart Disease | Coronary Arteriosclerosis

United States, Canada
Rigshospitalet, Denmark
Danish Heart Foundation; Copenhagen Hospital Corporation

Terminated

Cleansing of Suction Blood in Cardiac Surgery for Reduced Inflammatory Response

Systemic Inflammatory Response Syndrome | Coronary Arteriosclerosis

Denmark
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cholesterol-Lowering Atherosclerosis Study (CLAS)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Cerebrovascular Disorders | Coronary Disease | Arterial Occlusive Diseases | Atherosclerosis | Carotid Artery Diseases | Coronary Arteriosclerosis | Cerebral Arteriosclerosis
Charite University, Berlin, Germany

Completed

Release of Epoxyeicosatrienoic Acids From Erythrocytes During the Use of Extracorporeal Procedures (Heart-lung Machine)

Coronary Arteriosclerosis | Valve Heart Disease

Germany
Hospital San Carlos, Madrid
Laboratorios Farmacéuticos Rovi, S.A.; S&H MEDICAL SCIENCE SERVICE, S.L.

Active, not recruiting

Registry of Secondary Revascularization (REVASEC)

Coronary Arteriosclerosis | Stent Stenosis | Coronary Artery Disease Progression | Stent Restenosis | Coronary Artery Disease of Significant Bypass Graft

Spain
Shaare Zedek Medical Center
Hebrew University of Jerusalem

Completed

Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

Myocardial Infarction | Coronary Arteriosclerosis | Angina Unstable
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Endothelial Progenitor Cells and Risk Factors for Coronary Artery Disease

Coronary Arteriosclerosis

United States
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) (WAFACS)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Coronary Arteriosclerosis
Ankara City Hospital Bilkent

Recruiting

Comparison of Airway Management With Bronchial Blocker and Double-Lumen Tube in Single-Lung Ventilation

Coronary Arteriosclerosis | One-lung Ventilation | Heart Valvular Disease

Turkey
University of Colorado, Denver

Terminated

Impact of Daylight on Patients With Acute Myocardial Infarction

Myocardial Infarction | Coronary Arteriosclerosis

United States
Johns Hopkins University
Duke University; Maryland Medical Research Institute

Completed

Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery

Angina Pectoris | Coronary Arteriosclerosis

United States
Organon and Co
PT. Schering-Plough. Tbk Indonesia

Completed

Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)

Hypercholesterolemia | Coronary Arteriosclerosis
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA

Heart Diseases | Cardiovascular Diseases | Inflammation | Thrombosis | Atherosclerosis | Coronary Arteriosclerosis
Yonsei University
Chong Kun Dang Pharmaceutical Corp.

Unknown

Assessment of Change in Atherosclerotic Plaque by Serial CCTA (ACROSS)

Coronary Artery Disease | Coronary Arteriosclerosis | Hydroxymethylglutaryl-CoA Reductase Inhibitors

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...
MDS Pharma Services; Bio-Inova Life Sciences International

Completed

Comparative Atorvastatin Pleiotropic Effects (CAP)

Hypercholesterolemia | Coronary Arteriosclerosis

Canada, France, Russian Federation, Slovakia, Poland, Czechia, Romania
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Not yet recruiting

SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective (SPAGO)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Artery Lesion | Stenosis Coronary
China National Center for Cardiovascular Diseases

Unknown

Risk Factors of Intermediate Coronary Lesion Progression

Coronary Angiography | Coronary Atheroscleroses

China
Cytori Therapeutics

Completed

A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium

Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Ischemic Heart Disease | Coronary Arteriosclerosis

Spain, Denmark, Netherlands
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)

Myocardial Infarction | Coronary Arteriosclerosis

Canada
Pfizer

Completed

A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease (ILLUSTRATE)

Coronary Disease | Coronary Arteriosclerosis | Hyperlipidemia

United States, Spain, Canada, Poland, Belgium, Netherlands
Medtronic Cardiovascular

Completed

Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery (MICS)

Arteriosclerosis of Coronary Artery Bypass Graft

Canada, United States
University Hospital, Rouen
Bristol-Myers Squibb; GE Healthcare; Fédération Française de Cardiologie; Société... and other collaborators

Completed

Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)

Myocardial Infarction | Myocardial Ischemia | Coronary Arteriosclerosis | Heart Failure, Congestive | Myocardial Stunning

France, Belgium
Cytori Therapeutics

Completed

Randomized Clinical Trial of Adipose-Derived Stem Cells in the Treatment of Pts With ST-elevation Myocardial Infarction

Myocardial Infarction | Coronary Disease | Cardiovascular Disease | Coronary Arteriosclerosis

Spain, Netherlands
Fondazione Evidence per Attività e Ricerche Cardiovascolari...

Recruiting

AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease (GINGER)

Coronary Restenosis

Italy
Biotronik AG

Completed

Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis. (BIOLUX-RCT)

Coronary Artery Disease | Coronary Restenosis

Germany, Latvia
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Abbott Medical Devices

Completed

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Switzerland, Netherlands, Spain, France, Sweden, Poland, Germany, Belgium, Denmark, Italy, United Kingdom
Sarepta Therapeutics, Inc.
Baim Institute for Clinical Research

Completed

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

Coronary Artery Disease | Coronary Restenosis

Germany
Scripps Health

Completed

SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents

Coronary Artery Disease | Coronary Restenosis

United States
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort B (ABSORB B)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Netherlands, Poland, France, Denmark, Australia, Switzerland, Belgium
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
Abbott Medical Devices

Completed

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Thailand, Israel, Spain, Italy, United Kingdom, Malaysia, Austria, France, Germany, Poland
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Charite University, Berlin, Germany
Techniker Krankenkasse

Completed

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents (GERSHWIN)

Coronary Artery Disease

Germany
German Heart Institute
Novartis

Unknown

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Coronary Artery Disease | Coronary Restenosis

Germany
Deutsches Herzzentrum Muenchen

Completed

Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)

Renal Insufficiency, Chronic | Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Samsung Medical Center

Withdrawn

DEB Versus 2nd Generation DES in Patients With In-Scaffold Restenosis of Bioresorbable Vascular Scaffold (SMART-BRS-ISR)

Coronary Artery Disease | Coronary Restenosis

Korea, Republic of
SIS Medical AG

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (AbsorbISR)

Coronary Artery Disease | Coronary Restenosis

Switzerland
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany

Clinical Trials on Coronary Arteriosclerosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations